Oral antiviral treatment for COVID-19: a comprehensive review on nirmatrelvir/ritonavir K Akinosoglou, G Schinas, C Gogos Viruses 14 (11), 2540, 2022 | 44 | 2022 |
The impact of age on intensive care K Akinosoglou, G Schinas, MP Almyroudi, C Gogos, G Dimopoulos Ageing Research Reviews 84, 101832, 2023 | 20 | 2023 |
COVID-19 vaccination in patients with chronic liver disease G Schinas, E Polyzou, F Mitropetrou, A Pazionis, C Gogos, C Triantos, ... Viruses 14 (12), 2778, 2022 | 12 | 2022 |
COVID-19 Pharmacotherapy in pregnancy: a literature review of current therapeutic choices K Akinosoglou, G Schinas, EA Rigopoulos, E Polyzou, A Tzouvelekis, ... Viruses 15 (3), 787, 2023 | 9 | 2023 |
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial EJ Giamarellos-Bourboulis, A Siampanos, A Bolanou, S Doulou, ... The Lancet Respiratory Medicine 12 (4), 294-304, 2024 | 8 | 2024 |
Preventing multidrug-resistant bacterial transmission in the intensive care unit with a comprehensive approach: a policymaking manual G Schinas, E Polyzou, N Spernovasilis, C Gogos, G Dimopoulos, ... Antibiotics 12 (8), 1255, 2023 | 8 | 2023 |
Association of Antiretroviral Therapy with Platelet Function and Systemic Inflammatory Response in People Living with HIV: A Cross-Sectional Study K Akinosoglou, M Kolosaka, G Schinas, AL Delastic, S Antonopoulou, ... Microorganisms 11 (4), 958, 2023 | 8 | 2023 |
Immune-mediated liver injury following COVID-19 vaccination G Schinas, E Polyzou, V Dimakopoulou, S Tsoupra, C Gogos, ... World Journal of Virology 12 (2), 100, 2023 | 7 | 2023 |
High-dose nebulized colistin methanesulfonate and the role in hospital-acquired pneumonia caused by Gram-negative bacteria with difficult-to-treat resistance: a review I Karaiskos, A Gkoufa, E Polyzou, G Schinas, Z Athanassa, K Akinosoglou Microorganisms 11 (6), 1459, 2023 | 6 | 2023 |
Early fluvoxamine reduces the risk for clinical deterioration in symptomatic outpatients with Covid-19: a real-world, retrospective, before–after analysis A Tsiakalos, PD Ziakas, E Polyzou, G Schinas, K Akinosoglou Microorganisms 11 (8), 2073, 2023 | 4 | 2023 |
COVID-19 Outcomes and Diabetes Mellitus: A Comprehensive Multicenter Prospective Cohort Study K Akinosoglou, G Schinas, E Bletsa, M Bristianou, L Lanaras, ... Microorganisms 11 (6), 1416, 2023 | 4 | 2023 |
Remdesivir Use in the Real-World Setting: An Overview of Available Evidence K Akinosoglou, EA Rigopoulos, G Schinas, G Kaiafa, E Polyzou, ... Viruses 15 (5), 1167, 2023 | 4 | 2023 |
Clinical outcomes in vaccinated and unvaccinated patients with COVID-19: a population-based analysis. O Papaioannou, T Karampitsakos, P Tsiri, V Sotiropoulou, E Koulousousa, ... European Review for Medical & Pharmacological Sciences 26 (20), 2022 | 4 | 2022 |
Understanding and implementing diagnostic stewardship: a guide for resident physicians in the era of antimicrobial resistance G Schinas, G Dimopoulos, K Akinosoglou Microorganisms 11 (9), 2214, 2023 | 3 | 2023 |
Targeting CMV reactivation to optimize care for critically Ill COVID-19 patients: a review on the therapeutic potential of antiviral treatment G Schinas, V Moustaka, E Polyzou, MP Almyroudi, G Dimopoulos, ... Viruses 15 (5), 1165, 2023 | 3 | 2023 |
Remdesivir: Effectiveness and Safety in Hospitalized Patients with COVID-19 (ReEs-COVID-19)—Analysis of Data from Daily Practice N Pantazis, E Pechlivanidou, A Antoniadou, K Akinosoglou, I Kalomenidis, ... Microorganisms 11 (8), 1998, 2023 | 2 | 2023 |
Testing Hepatitis E Seroprevalence among HIV-Infected Patients in Greece: THE SHIP Study N Antonopoulou, G Schinas, Z Kotsiri, O Tsachouridou, K Protopapas, ... Pathogens 13 (7), 536, 2024 | 1 | 2024 |
Antimicrobial resistance rates of urogenital Mycoplasma hominis and Ureaplasma species before and during the COVID-19 pandemic: results from a Greek survey … K Akinosoglou, A Tsiakalos, ID Dimopoulou, G Schinas, E Polyzou, ... The Journal of Antibiotics 77 (2), 120-125, 2024 | 1 | 2024 |
Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein K Iliopoulou, P Koufargyris, S Doulou, E Tasouli, S Katopodis, ... Infectious Diseases and Therapy 13 (1), 105-119, 2024 | 1 | 2024 |
Increased levels of galectin-3 in critical COVID-19 I Nikitopoulou, AG Vassiliou, N Athanasiou, E Jahaj, K Akinosoglou, ... International Journal of Molecular Sciences 24 (21), 15833, 2023 | 1 | 2023 |